1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2016

Antiangiogenic therapy in pancreatic neuroendocrine tumors

Capozzi, M., Von Arx, C., De Divitiis, C., Ottaiano, A., Tatangelo, F., Romano, G. M. & Tafuto, S., Oct 1 2016, In : Anticancer Research. 36, 10, p. 5025-5030 6 p.

Research output: Contribution to journalReview article

2017

Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials

Ottaiano, A., Capozzi, M., De Divitiis, C., De Stefano, A., Botti, G., Avallone, A. & Tafuto, S., Mar 4 2017, In : Acta Oncologica. 56, 3, p. 377-383 7 p.

Research output: Contribution to journalReview article

2018

First biologic drug in the treatment of RAS wild-type metastatic colorectal cancer: Anti-EGFR or Bevacizumab? Results from a meta-analysis

Ottaiano, A., De Stefano, A., Capozzi, M., Nappi, A., De Divitiis, C., Romano, C., Silvestro, L., Cassata, A., Casaretti, R., Tafuto, S., Caraglia, M., Berretta, M., Nasti, G. & Avallone, A., May 3 2018, In : Frontiers in Pharmacology. 9, MAY, 441.

Research output: Contribution to journalReview article

2019

Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment

Capozzi, M., De Divitiis, C., Ottaiano, A., von Arx, C., Scala, S., Tatangelo, F., Delrio, P. & Tafuto, S., 2019, In : Cancer Management and Research. 11, p. 3847-3860 14 p.

Research output: Contribution to journalReview article

Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms

von Arx, C., Capozzi, M., López-Jiménez, E., Ottaiano, A., Tatangelo, F., Di Mauro, A., Nasti, G., Tornesello, M. L. & Tafuto, S., Aug 22 2019, In : Journal of Clinical Medicine. 8, 9

Research output: Contribution to journalReview article